Lunai Bioworks (LNAI) Gains from Investment Securities (2019 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Gains from Investment Securities of $70000.0 in Q1 2026, down 50.0% quarter-over-quarter from $140000.0 in Q4 2025, and down 98.38% on a YoY basis from $4.3 million in Q1 2025.
Lunai Bioworks (LNAI) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Lunai Bioworks' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $70000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 98.38% year-over-year to $70000.0; the TTM figure through Mar 2026 stood at -$10.4 million (down 168.35% YoY), while the FY2024 annual figure was -$3.0 million, changed N/A from the prior year.
- Gains from Investment Securities was $70000.0 for Q1 2026 at Lunai Bioworks, down from $140000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $9.2 million in Q3 2024 to a low of -$11.0 million in Q2 2025.
- Historically, Gains from Investment Securities has averaged -$274242.6 across 3 years, with a median of $140000.0 in 2025.
- Biggest YoY gain for Gains from Investment Securities was 159.4% in 2025; the steepest drop was 359.14% in 2025.
- A 3-year view of Gains from Investment Securities shows it stood at -$2.6 million in 2024, then soared by 105.41% to $140000.0 in 2025, then tumbled by 50.0% to $70000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $70000.0 (Q1 2026), $140000.0 (Q4 2025), and $370000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,000.00 |
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 370,000.00 |
| Sep 30, 2025 | 370,000.00 |
| Jun 30, 2025 | -10.99 Mn |
| Jun 30, 2025 | -10.99 Mn |
| Mar 31, 2025 | 4.33 Mn |
| Mar 31, 2025 | 4.33 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | 9.25 Mn |
| Sep 30, 2024 | 9.25 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | -7.29 Mn |
| Mar 31, 2024 | -7.29 Mn |
| Sep 30, 2021 | 34.00 |
| Sep 30, 2021 | 34.00 |